Sterling, VA and Loveland, CO 6/22/15; Loveland, CO 7/28/15—Hach has agreed to acquire publicly held Sutron for a purchase price of $8.50 per share, or approximately $39 million net of cash. Sutron will join Hach Environmental, whose companies, including Ott Hydromet and Sea-Bird Scientific, offer environmental monitoring solutions for natural resource and oceanographic applications. “Sutron […]
With the first half of the year behind us, let us reflect on the state of the analytical and life science instrumentation and lab products market, how it has developed thus far and what is in store for the rest of 2015. The original January forecast (see IBO 1/15/15) was published without the benefit of […]
This month, Eurostat released its annual yearbook, which included data on R&D expenditure and personnel for the continent from 2004 to 2013. The figures showed growth in both investment in R&D and the numbers of researchers over the years covered, and provided information on researcher numbers and R&D expenditures by sector. The data suggest that […]
Tokyo, Japan and Hilden, Germany 6/18/15—Hitachi High Technologies and QIAGEN have entered into a long-term strategic collaboration for molecular testing for life science and IVD. Hitachi High-Technologies will contribute its instrument development and manufacturing technologies, while QIAGEN will provide molecular sample-to-insight solutions. Initially, the collaboration will focus on automated systems for PCR and NGS. The […]
Courbevoie, France 6/29/15—Nuclear and renewable energy firm AREVA has announced that it plans to sell its Canberra business. Canberra provides nuclear measurement systems and instrumentation, including products for waste characterization and lab measurements. Headquartered in Connecticut with over one thousand employees worldwide, Canberra generated€180 million ($240 million = €0.75 = $1) in sales in 2014. […]
Aubagne, France and Goettingen, Germany 7/2/15—Sartorius Stedim Biotech (SSB) has acquired Cellca for an undisclosed amount. Cellca provides process-development services for biopharmaceutical and biosimilar companies. Based in Germany with around 30 employees, Cellca posted 2014 revenues of €6 million ($8 million = €0.75 = $1). “Together with our single-use products, media and testing services, we […]
Wilmington, DE 7/13/15—454 Life Sciences, a Roche business, has filed a patent infringement suit in the US District Court in Delaware against Ion Torrent, a Thermo Fisher Scientific business. The complaint alleges infringement of three patents related to performing emulsion PCR and DNA sequencing of emulsion PCR products: US Patent Nos. 7,323,305 (Methods of Amplifying […]
Rishon LeZion, Israel 7/14/15—Citing anonymous sources, Israel’s Globes newspaper reports that Danaher has signed a letter of intent to purchase Applied Spectral Imaging (ASI) for $30 million. Headquartered in Israel, ASI provides computer imaging solutions for microscopes for genetic testing applications. ASI sells software and hardware. Its products are FDA approved. The newspaper reports that […]
For only the second time in five years, median R&D spending for 22 major publicly held analytical instrument and lab product companies (see table, page 6) climbed at a faster rate than revenues. In 2014, the companies’ median R&D spending advanced 7.3%, while sales grew 5.2%. Consequently, total R&D spending as a percentage of sales […]
Since its introduction in 2013, the use of the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) 9 system for genome editing has exploded. Products for CRISPR/Cas9 range from plasmids and oligonucleotides to transgenic animals and screening services. According to Bioinformatics LLC’s report, “The Market for CRISPR/Cas9 Genome Editing Products,” published in May and based […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
